Related Experiment Videos

[Hypertrophic cardiomyopathy: mode of death and pathological findings]

H Fujiwara1, M Tanaka, T Onodera

  • 1Department of Internal Medicine, Kyoto University Hospital.

Journal of Cardiology. Supplement
|January 1, 1987
PubMed

Insights

Sudden death in hypertrophic cardiomyopathy (HCM) is linked to greater myocyte fibrosis and disarray, not hypertrophy. Heart failure deaths show extensive fibrosis and myocyte disarray in dilated ventricles.

Area of Science:

  • Cardiovascular Pathology
  • Cardiac Hypertrophy Research
  • Sudden Cardiac Death Etiology

Background:

  • Hypertrophic cardiomyopathy (HCM) is a primary cause of sudden cardiac death.
  • Understanding pathological differences across HCM death modes is crucial for risk stratification.

Purpose of the Study:

  • To investigate the relationship between modes of death and pathological parameters in hypertrophic cardiomyopathy.
  • To quantitatively analyze myocyte disarray, fibrosis, and size in relation to death cause.

Main Methods:

  • Quantitative histological analysis of myocyte disarray and fibrosis in 22 autopsied HCM subjects.
  • Categorization of subjects into sudden death, heart failure, and control groups.
  • Image analysis of interventricular septum and left ventricular free wall.

Main Results:

  • Sudden death group exhibited significantly greater fibrosis and myocyte disarray compared to controls.
  • No significant differences in hypertrophy parameters (heart weight, wall thickness, myocyte size) between sudden death and control groups.
  • Heart failure group showed extensive replacement fibrosis and myocyte disarray, particularly with dilated left ventricular cavities.

Conclusions:

  • Myocyte disarray and fibrosis, rather than hypertrophy, are key pathological features associated with sudden death in HCM.
  • Distinct pathological patterns exist between sudden death and heart failure in HCM patients.

Related Concept Videos